ImmunityBio to begin Covid-19 vaccine candidate trial in South Africa
ImmunityBio is set to initiate a Phase I clinical trial of its novel subcutaneous Covid-19...
ImmunityBio is set to initiate a Phase I clinical trial of its novel subcutaneous Covid-19...
ViiV Healthcare has announced positive data from an interim analysis of the HIV Prevention Trials...
Pfizer and BioNTech have started participant enrolment in a Phase III clinical trial of their...
US-based biotechnology company Novavax has launched a Phase IIb clinical trial of its Covid-19 vaccine...
Researchers in South Africa and Brazil have initiated clinical trials to assess a Covid-19 vaccine...
The National Institute of Allergy and Infectious Diseases (NIAID) in the US has stopped vaccine...
Johnson & Johnson (J&J) has completed enrolment procedures for the Phase IIb Imbokodo clinical trial...